BEGIN:VCALENDAR
PRODID:-//AddEvent Inc//AddEvent.com v1.7//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:STANDARD
DTSTART:20221030T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20220327T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20220811T122634Z
STATUS:CONFIRMED
UID:1660220794addeventcom
SEQUENCE:0
DTSTART;TZID=Europe/Madrid:20220912T161500
DTEND;TZID=Europe/Madrid:20220912T171500
SUMMARY:SP 2205 – Various oncologic interventions
DESCRIPTION:Title: SP 2205 – Various oncologic interventions\n\nType: Scientific Paper Session\n\nTopics: Aortic Intervention\, Interventional Oncology\, IR Management\, Non-vascular Intervention\n\n2022\, September 12 | 16:15 - 17:15 (Europe/Madrid)\nRoom 113\n\nScheduled lectures:\n\n2205.1 / Oncological and peri-operative outcomes of cryoablation of renal cell carcinoma for patients with hereditary RCC diseases - an analysis of European multinational prospective EuRECA registry\n- W. Chan\n\n2205.2 / Outcome evaluation of percutaneous cryoablation for the treatment of primary and metastatic lung lesions: preliminary results from a Greek multicenter trial\n- D. Stefanou\n\nCryoablation of breast cancer in metastatic patients: a single institutional experience\n- C. Pusceddu\n\n2205.4 / Percutaneous cryoablation for local tumor control of sarcoma pulmonary metastases in oligometastatic patients\n- E. Efthymiou\n\n2205.5 / Cone beam CT guided histotripsy targeting - an in vivo porcine study\n- M. Wagner\n\n2205.6 / Adjuvant Holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients\, a dose-finding study (HORA EST HCC trial): follow-up\n- P. Hendriks\n\n2205.7 / Transperineal laser ablation of benign and malignant prostate disease\n- E. Walser\n\nVisit https://programme.cirse2022.cirse.org to watch live and on demand!
X-ALT-DESC;FMTTYPE=text/html:Title: SP 2205 – Various oncologic interventions<br><br>Type: Scientific Paper Session<br><br>Topics: Aortic Intervention, Interventional Oncology, IR Management, Non-vascular Intervention<br><br>2022, September 12 | 16:15 - 17:15 (Europe/Madrid)<br>Room 113<br><br>Scheduled lectures:<br><br>2205.1 / Oncological and peri-operative outcomes of cryoablation of renal cell carcinoma for patients with hereditary RCC diseases - an analysis of European multinational prospective EuRECA registry<br>- W. Chan<br><br>2205.2 / Outcome evaluation of percutaneous cryoablation for the treatment of primary and metastatic lung lesions: preliminary results from a Greek multicenter trial<br>- D. Stefanou<br><br>Cryoablation of breast cancer in metastatic patients: a single institutional experience<br>- C. Pusceddu<br><br>2205.4 / Percutaneous cryoablation for local tumor control of sarcoma pulmonary metastases in oligometastatic patients<br>- E. Efthymiou<br><br>2205.5 / Cone beam CT guided histotripsy targeting - an in vivo porcine study<br>- M. Wagner<br><br>2205.6 / Adjuvant Holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients, a dose-finding study (HORA EST HCC trial): follow-up<br>- P. Hendriks<br><br>2205.7 / Transperineal laser ablation of benign and malignant prostate disease<br>- E. Walser<br><br>Visit https://programme.cirse2022.cirse.org to watch live and on demand!
LOCATION:Room 113
TRANSP:OPAQUE
END:VEVENT
END:VCALENDAR